TIGERMED Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Possible Interim Dividend

Bulletin Express

Aug 18

Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has announced that its board of directors will convene on 28 August 2026. The agenda includes:

• Reviewing and approving the unaudited interim results for the six months ended 30 June 2026. • Considering the declaration and payment of an interim dividend, if applicable.

The notification was released on 18 August 2026 under the signature of Chairman Ye Xiaoping. TIGERMED’s current board comprises three executive directors (Dr. Ye Xiaoping, Ms. Cao Xiaochun and Mr. Wen Zengyu), one employee director (Mr. Wu Hao) and three independent non-executive directors (Mr. Yuan Huagang, Ms. Liu Yuwen and Mr. Siu Paul Yu Hay).

Market participants will receive the company’s interim performance update and any dividend decision following the board meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1117168289"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1117168289\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1117168289?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-18 17:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117168289","market":"hk","top_or_hot":-1,"title":"TIGERMED Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Possible Interim Dividend","media":"Bulletin Express","content":"<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has announced that its board of directors will convene on 28 August 2026. The agenda includes:</p>\n<p>• Reviewing and approving the unaudited interim results for the six months ended 30 June 2026.  \n• Considering the declaration and payment of an interim dividend, if applicable.</p>\n<p>The notification was released on 18 August 2026 under the signature of Chairman Ye Xiaoping. TIGERMED’s current board comprises three executive directors (Dr. Ye Xiaoping, Ms. Cao Xiaochun and Mr. Wen Zengyu), one employee director (Mr. Wu Hao) and three independent non-executive directors (Mr. Yuan Huagang, Ms. Liu Yuwen and Mr. Siu Paul Yu Hay).</p>\n<p>Market participants will receive the company’s interim performance update and any dividend decision following the board meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TIGERMED Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Possible Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTIGERMED Schedules 28 Aug 2026 Board Meeting to Approve H1 2026 Results and Possible Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-18 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has announced that its board of directors will convene on 28 August 2026. The agenda includes:</p>\n<p>• Reviewing and approving the unaudited interim results for the six months ended 30 June 2026.  \n• Considering the declaration and payment of an interim dividend, if applicable.</p>\n<p>The notification was released on 18 August 2026 under the signature of Chairman Ye Xiaoping. TIGERMED’s current board comprises three executive directors (Dr. Ye Xiaoping, Ms. Cao Xiaochun and Mr. Wen Zengyu), one employee director (Mr. Wu Hao) and three independent non-executive directors (Mr. Yuan Huagang, Ms. Liu Yuwen and Mr. Siu Paul Yu Hay).</p>\n<p>Market participants will receive the company’s interim performance update and any dividend decision following the board meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03347","symbol_name":"泰格医药","start_time":0,"source_url":"","article_id":"1117168289","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117168289","pubTimestamp":1787046317,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has announced that its board of directors will convene on 28 August 2026. The agenda includes: • Reviewing and approving the unaudited interim...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03347":"泰格医药"},"translate_title":"泰格医药定于 2026 年 8 月 28 日召开董事会会议，批准 2026 年上半年业绩和可能的中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03347":1},"content_text":"Hangzhou Tigermed Consulting Co., Ltd. (TIGERMED) has announced that its board of directors will convene on 28 August 2026. The agenda includes:\n• Reviewing and approving the unaudited interim results for the six months ended 30 June 2026.  \n• Considering the declaration and payment of an interim dividend, if applicable.\nThe notification was released on 18 August 2026 under the signature of Chairman Ye Xiaoping. TIGERMED’s current board comprises three executive directors (Dr. Ye Xiaoping, Ms. Cao Xiaochun and Mr. Wen Zengyu), one employee director (Mr. Wu Hao) and three independent non-executive directors (Mr. Yuan Huagang, Ms. Liu Yuwen and Mr. Siu Paul Yu Hay).\nMarket participants will receive the company’s interim performance update and any dividend decision following the board meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}